EUVIMEDEUVIMED entdecken
Crossref

CEBPA and DNMT3A Methylation and Expression Profiles Predict Survival in Acute Myeloid Leukemia

Jairo Javier Jattin Balcázar iD

International Journal of Laboratory Hematology · 2026-12 · 48 (6) · 1428-1435

DOI: 10.1111/ijlh.70225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, online erschienen am 14.08.2026. Verfasst von Jairo Javier Jattin Balcázar. Beteiligte Einrichtung: Faculty of Medicine, Universidad Nacional de Colombia - Sede Bogotá, Bogotá, Colombia. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, DNA Methylation, DNA (Cytosine-5-)-Methyltransferases, CCAAT-Enhancer-Binding Proteins. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Acute myeloid leukemia (AML) is a genetically heterogeneous malignancy with variable clinical outcomes. Epigenetic alterations, particularly DNA methylation, have emerged as key modulators of gene expression and disease progression. This study investigates the prognostic relevance of methylation and expression profiles of CEBPA and DNMT3A in AML.

Methods

A cohort of adult AML patients from the TCGA‐LAML dataset was analyzed for gene expression and methylation profiles across seven AML‐associated genes. Survival associations were evaluated using Kaplan–Meier curves and Cox proportional hazards models. An initial panel of seven AML‐associated genes (CEBPA, DNMT3A, HDAC1, IDH1, IDH2, NPM1, and RUNX1) was screened for prognostic relevance using matched expression and methylation data; genes with significant survival associations were retained for model construction. Patients were stratified into low, intermediate, and high‐risk groups based on this score.

Results

Significant survival associations were observed for DNMT3A expression ( p = 0.0062) and CEBPA methylation ( p = 0.0074). Of the seven candidates, only DNMT3A expression and CEBPA methylation demonstrated independent prognostic value and were integrated into the final composite score. The composite score yielded strong survival separation across risk groups ( p = 0.0033). In the final multivariate Cox model ( n = 158), CEBPA methylation and DNMT3A expression remained independently predictive of overall survival.

Conclusion

Methylation and expression profiles of CEBPA and DNMT3A could be integrated into a composite molecular score to complement conventional genetic and cytogenetic classifications to stratify survival risk in AML; however, further studies with established clinical risk systems are required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteDNA MethylationDNA (Cytosine-5-)-MethyltransferasesCCAAT-Enhancer-Binding ProteinsGene Expression Regulation, LeukemicHumansNucleophosminDNA Methyltransferase 3AFemalePrognosisMaleMiddle AgedAdultAged

Stichwörter der Autor:innen

acute myeloid leukemiabiomarkersprognosis

Substanzen

NucleophosminDNA Methyltransferase 3ANPM1 protein, humanDNA (Cytosine-5-)-MethyltransferasesDNMT3A protein, humanCEBPA protein, humanCCAAT-Enhancer-Binding Proteins

Autor:innen und Institutionen

  • Faculty of Medicine, Universidad Nacional de Colombia - Sede Bogotá, Bogotá, Colombia.

ORCID-Profile: Jairo Javier Jattin Balcázar

Zitieren

APA

Jattin Balcázar, J. J. (2026). CEBPA and DNMT3A Methylation and Expression Profiles Predict Survival in Acute Myeloid Leukemia. International Journal of Laboratory Hematology, 48(6), 1428-1435. https://doi.org/10.1111/ijlh.70225

Vancouver

Jattin Balcázar JJ. CEBPA and DNMT3A Methylation and Expression Profiles Predict Survival in Acute Myeloid Leukemia. International Journal of Laboratory Hematology. 2026;48(6):1428-1435. doi:10.1111/ijlh.70225

BibTeX
@article{JattinBalczar2026,
  author = {Jattin Balcázar, Jairo Javier},
  title = {CEBPA and DNMT3A Methylation and Expression Profiles Predict Survival in Acute Myeloid Leukemia},
  journal = {International Journal of Laboratory Hematology},
  year = {2026},
  volume = {48},
  number = {6},
  pages = {1428--1435},
  doi = {10.1111/ijlh.70225}
}
Kostenlos starten →